Blood and bronchoalveolar lavage fluid acetylcholinesterase levels following microinstillation inhalation exposure to sarin in guinea pigs

Inhalation Toxicology

Volumn 20, Issue 9, 2008, Pages 821-828

  Che, Magnus M ^a   Conti, Michele ^b   Boylan, Megan ^b   Sciuto, Alfred M ^b   Gordon, Richard K ^a   Nambiar, Madhusoodana P ^a,c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; SARIN;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; GUINEA PIG; LC 50; LUNG INJURY; LUNG LAVAGE; LUNG TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; BUTYRYLCHOLINESTERASE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; LONGEVITY; LUNG; LUNG DISEASES; MALE; SARIN;

ANIMALIA; CAVIA;

EID: 47749144001     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370802050957     Document Type: Article

References (49)

1. Abdel-Rahman, A., Shetty, A. K., and Abou-Donia, M. B. 2002. Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: Dose-response relationships. Neuroscience 113:721-741.
2. Allon, N., Rabinovitz, I., Manistersky, E., Weissman, B. A., and Grauer, E. 2005. Acute and long-lasting cardiac changes following a single whole-body exposure to sarin vapor in rats. Toxicol. Sci. 87:385-390.
3. Anthony, J. S., Haley, M., Manthei, J., Way, R., Burnett, D., Gaviola, B., Sommerville, D., Crosier, R., Mioduszewski, R., Thomson, S., Crouse, C., and Matson, K. 2004. Inhalation toxicity of cyclosarin (GF) vapor in rats as a function of exposure concentration and duration: Potency comparison to sarin (GB). Inhal. Toxicol. 16:103-111.
4. Anzueto, A., deLemos, R. A., Seidenfeld, J., Moore, G., Hamil, H., Johnson, D., and Jenkinson, S. G. 1990. Acute inhalation toxicity of soman and sarin in baboons. Fundam. Appl. Toxicol. 14:676-687.
5. Bajgar, J. 2004. Organophosphates/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 38:151-216.
6. Bajgar, J., Sevelova, L., Krejcova, G., Fusek, J., Vachek, J., Kassa, J., Herink, J., de Jong, L. P., and Benschop, H. P. 2004. Biochemical and behavioral effects of soman vapors in low concentrations. Inhal. Toxicol. 16:497-507.
7. Bartosova-Sevelova, L., and Bajgar, J. 2005. Changes of acetylcholinesterase activity after long-term exposure to sarin vapors in rats. Hum. Exp. Toxicol. 24:363-367.
8. Benschop, H. P., Trap, H. C., Spruit, H. E., van der Wiel, H. J., Langenberg, J. P., and de Jong, L. P. 1998. Low level nose-only exposure to the nerve agent soman: Toxicokinetics of soman stereoisomers and cholinesterase inhibition in atropinized guinea pigs. Toxicol. Appl. Pharmacol. 153:179-185.
9. Bide, R. W., and Risk, D. J. 2004. Inhalation toxicity in mice exposed to sarin (GB) for 20-720 min. J. Appl. Toxicol. 24:459-467.
10. Buchanan, K. C., Burge, R. R., and Ruble, G. R. 1998. Evaluation of injectable anesthetics for major surgical procedures in guinea pigs. Contemp. Top. Lab. Anim. Sci. 37:58-63.
11. Cohan, S. L., Pohlmann, J. L., Mikszewski, J., and O'Doherty, D. S. 1976. The pharmacokinetics of pyridostigmine. Neurology 26:536-539.
12. Dabisch, P. A., Burnett, D. C., Miller, D. B., Jakubowski, E. M., Muse, W. T., Forster, J. S., Scotto, J. A., Jarvis, J. R., Davis, E. A., Hulet, S. W., Reutter, S. A., Mioduszewski, R. J., and Thomson, S. A. 2005. Tolerance to the miotic effect of sarin vapor in rats after multiple low-level exposures. J. Ocul. Pharmacol. Ther. 21:182-195.
13. Damodaran, T. V., Greenfield, S. T., Patel, A. G., Dressman, H. K., Lin, S. K., and Abou-Donia, M. B. 2006. Toxicogenomic studies of the rat brain at an early time point following acute sarin exposure. Neurochem. Res. 31:367-381.
14. Damodaran, T. V., Jones, K. H., Patel, A. G., and Abou-Donia, M. B. 2003. Sarin (nerve agent GB)-induced differential expression of mRNA coding for the acetylcholinesterase gene in the rat central nervous system. Biochem. Pharmacol. 65:2041-2047.
15. DeLorenzo, R. A. 2001. Exposed. Signs, symptoms & EMS management of nerve-agent poisoning. J. Emerg. Med. Serv. 26:48-57.
16. Ellman, G. L., and Callaway, E. 1961. Erythrocyte cholinesterase levels in mental patients. Nature 192:1216.
17. Graham, J. R., Wright, B. S., Rezk, P. E., Gordon, R. K., Sciuto, A. M., and Nambiar, M. P. 2006. Butyrylcholinesterase in guinea pig lung lavage: A novel biomarker to assess lung injury following inhalation exposure to nerve agent VX. Inhal. Toxicol. 18:493-500.
18. Henderson, R. F., Barr, E. B., Blackwell, W. B., Clark, C. R., Conn, C. A., Kalra, R., March, T. H., Sopori, M. L., Tesfaigzi, Y., Menache, M. G., and Mash, D. C. 2002. Response of rats to low levels of sarin. Toxicol. Appl. Pharmacol. 184:67-76.
19. Henderson, R. F., Barr, E. B., Blackwell, W. B., Clark, C. R., Conn, C. A., Kalra, R., March, T. H., Sopori, M. L., Tesfaigzi, Y., Menache, M. G., Mash, D. C., Dokladny, K., Kozak, W., Kozak, A., Wachulec, M., Rudolph, K., Kluger, M. J., Singh, S. P., Razani-Boroujerdi, S., and Langley, R. J. 2001. Response of F344 rats to inhalation of subclinical levels of sarin: Exploring potential causes of Gulf War illness. Toxicol. Ind. Health 17:294-297.
20. Husain, K., Vijayaraghavan, R., Pant, S. C., Raza, S. K., and Pandey, K. S. 1993. Delayed neurotoxic effect of sarin in mice after repeated inhalation exposure. J. Appl. Toxicol. 13:143-145.
21. Inoue, N. 2003. [Neurological effects of chemical and biological weapons]. Rinsho Shinkeigaku 43:880-882.
22. Kadivar, H., and Adams, S. C. 1991. Treatment of chemical and biological warfare injuries: insights derived from the 1984 Iraqi attack on Majnoon Island. Mil. Med. 156:171-177.
23. Karalliedde, L., Gauci, C. A., and Carter, M. 1991. Chemical weapons. Br. Med. J. 302:474.
24. Kassa, J., Koupilova, M., and Vachek, J. 2001a. Long-term effects of low-level sarin inhalation exposure on the spatial memory of rats in a T-maze. Acta Med. (Hradec. Kralove) 44:93-96.
25. Kassa, J., Pecka, M., Tichy, M., Bajgar, J., Koupilova, M., Herink, J., and Krocova, Z. 2001b. Toxic effects of sarin in rats at three months following single or repeated low-level inhalation exposure. Pharmacol. Toxicol. 88:209-212.
26. Kassa, J., Krejcova, G., and Vachek, J. 2002. The impairment of spatial memory following low-level sarin inhalation exposure and antidotal treatment in rats. Acta Med. (Hradec. Kralove) 45:149-153.
27. Kassa, J., Krejcova, G., Skopec, F., Herink, J., Bajgar, J., Sevelova, L., Tichy, M., and Pecka, M. 2004. The influence of sarin on various physiological functions in rats following single or repeated low-level inhalation exposure. Inhal. Toxicol. 16:517-530.
28. Levy, A., Chapman, S., Cohen, G., Raveh, L., Rabinovitz, I., Manistersky, E., Kapon, Y., Allon, N., and Gilat, E. 2004. Protection and inflammatory markers following exposure of guinea pigs to sarin vapour: comparative efficacy of three oximes. J. Appl. Toxicol. 24:501-504.
29. Martin, T., and Lobert, S. 2003. Chemical warfare. Toxicity of nerve agents. Crit. Care Nurs. 23:15-20.
30. Masuda, N., Takatsu, M., Morinari, H., and Ozawa, T. 1995. Sarin poisoning in Tokyo subway. Lancet 345:1446.
31. Maxwell, D. M., and Brecht, K. M. 1991. The role of carboxylesterase in species variation of oxime protection against soman. Neurosci. Biobehav. Rev. 15:135-139.
32. Mioduszewski, R., Manthei, J., Way, R., Burnett, D., Gaviola, B., Muse, W., Thomson, S., Sommerville, D., and Crosier, R. 2002. Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats. Toxicol. Sci. 66:176-184.
33. Nambiar, M. P., Wright, B. S., Rezk, P. E., Smith, K. B., Gordon, R. K., Moran, T. S., Richards, S. M., and Sciuto, A. M. 2006. Development of a microinstillation model of inhalation exposure to assess lung injury following exposure to toxic chemicals and nerve agents in guinea pigs. Toxicol. Mech. Methods 16:295-306.
34. Nambiar, M. P., Gordon, R. K., Moran, T. S., Richards, S. M., and Sciuto, A. M. 2007. A simple method for accurate endotracheal placement of an intubation tube in guinea pigs to assess lung injury following chemical exposure. Toxicol. Mech. Methods 17:385-392.
35. Niven, A. S., and Roop, S. A. 2004. Inhalational exposure to nerve agents. Respir. Care Clin. North Am. 10:59-74.
36. Okumura, T., Suzuki, K., Fukuda, A., Kohama, A., Takasu, N., Ishimatsu, S., and Hinohara, S. 1998a. The Tokyo subway sarin attack: Disaster management, Part 2: Hospital response. Acad. Emerg. Med. 5:618-624.
37. Okumura, T., Suzuki, K., Fukuda, A., Kohama, A., Takasu, N., Ishimatsu, S., and Hinohara, S. 1998b. The Tokyo subway sarin attack: Disaster management, Part 3: National and international responses. Acad. Emerg. Med. 5:625-628.
38. Okumura, T., Takasu, N., Ishimatsu, S., Miyanoki, S., Mitsuhashi, A., Kumada, K., Tanaka, K., and Hinohara, S. 1996. Report on 640 victims of the Tokyo subway sarin attack. Ann. Emerg. Med. 28:129-135.
39. Ray, R., Clark, O. E. III, Ford, K. W., Knight, K. R., Harris, L. W., and Broomfield, C. A. 1991. A novel tertiary pyridostigmine derivative [3-(N, N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: Anticholinesterase properties and efficacy against soman. Fundam. Appl. Toxicol. 16:267-274.
40. Scheuch, G., Stahlhofen, W., and Heyder, J. 1996. An approach to deposition and clearance measurements in human airways. J. Aerosol Med. 9:35-41.
41. Segura, P., Chavez, J., Montano, L. M., Vargas, M. H., Delaunois, A., Carbajal, V., and Gustin, P. 1999. Identification of mechanisms involved in the acute airway toxicity induced by parathion. Naunyn Schmiedebergs Arch. Pharmacol. 360:699-710.
42. Sevelova, L., Vachek, J., and Bajgar, J. 2003. Inhalation apparatus for generating sarin and soman toxic vapors. Acta Med. (Hradec. Kralove) 46:157-161.
43. Shih, T., McDonough, J. H., Jr., and Koplovitz, I. 1999. Anticonvulsants for soman-induced seizure activity. J. Biomed. Sci. 6:86-96.
44. Spruit, H. E., Langenberg, J. P., Trap, H. C., van der Wiel, H. J., Helmich, R. B., van Helden, H. P., and Benschop, H. P. 2000. Intravenous and inhalation toxicokinetics of sarin stereoisomers in atropinized guinea pigs. Toxicol. Appl. Pharmacol. 169:249-254.
45. Vale, A. 2005. What lessons can we learn from the Japanese sarin attacks? Przegl. Lek. 62:528-532.
46. van Helden, H. P., Kuijpers, W. C., and Diemel, R.V. 2004a. Asthmalike symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: Therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal. Toxicol. 16:537-548.
47. van Helden, H. P., Trap, H. C., Kuijpers, W. C., Oostdijk, J. P., Benschop, H. P., and Langenberg, J. P. 2004b. Low-level exposure of guinea pigs and marmosets to sarin vapour in air: Lowest-observable-adverse-effect level (LOAEL) for miosis. J. Appl. Toxicol. 24:59-68.
48. van Helden, H. P., Vanwersch, R. A., Kuijpers, W. C., Trap, H. C., Philippens, I. H., and Benschop, H. P. 2004c. Low levels of sarin affect the EEG in marmoset monkeys: A pilot study. J. Appl. Toxicol. 24:475-483.
49. Wright, B. S., Rezk, P. E., Graham, J. R., Steele, K. E., Gordon, R. K., Sciuto, A. M., and Nambiar, M. P. 2006. Acute lung injury following inhalation exposure to nerve agent VX in guinea pigs. Inhal. Toxicol. 18:437-448.